Angelo Zanniti/LinkedIn
Jun 15, 2026, 13:05
Angelo Zanniti: Back from EHA 2026 Congress
Angelo Zanniti, Medical Biotechnologist at CEINGE Official Profile, shared a post on LinkedIn:
“Back from an inspiring few days at the EHA 2026 Congress in Stockholm.
It was a great opportunity to connect with colleagues, share experiences, and discover the latest advances in hematology and molecular diagnostics.
Conferences like these remind us how quickly our field is evolving and how important collaboration is in driving innovation and improving patient care.
Grateful for the experience and looking forward to putting new ideas into practice.”
Stay updated with Hemostasis Today.
-
Sep 19, 2026, 14:17Abdul Mannan: What Exactly Is a Platelet?
-
Sep 19, 2026, 13:39Keisuke Goda: Decoding Platelet Phenotypes in COVID-19 With Optofluidic Imaging
-
Sep 19, 2026, 13:30Targeted Thrombolysis Beyond tPA
-
Sep 19, 2026, 13:21Paul Armstrong: From Summer Studentship to Young Researcher
-
Sep 19, 2026, 13:06Rabiya Masood: Breaking the Cycle of Thalassemia Through Screening
-
Sep 19, 2026, 10:52Consuela A. Albright: The Critical Role of Black Blood Donors in Sickle Cell Treatment
-
Sep 19, 2026, 10:47Amber Yates: Inside Agios’ Partnership with the Sickle Cell Community
-
Sep 19, 2026, 10:46Anton Farkas: Mechanical Thrombectomy for Acute PE in Early Pregnancy
-
Sep 19, 2026, 10:40Marjolein Smidt: ASH Raises Ferritin Thresholds for Iron Deficiency